234 related articles for article (PubMed ID: 37832393)
1. Nicotine addiction: More than just dopamine.
Kim K; Picciotto MR
Curr Opin Neurobiol; 2023 Dec; 83():102797. PubMed ID: 37832393
[TBL] [Abstract][Full Text] [Related]
2. The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.
Antolin-Fontes B; Ables JL; Görlich A; Ibañez-Tallon I
Neuropharmacology; 2015 Sep; 96(Pt B):213-22. PubMed ID: 25476971
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based medication development for the treatment of nicotine dependence.
Xi ZX; Spiller K; Gardner EL
Acta Pharmacol Sin; 2009 Jun; 30(6):723-39. PubMed ID: 19434058
[TBL] [Abstract][Full Text] [Related]
4. Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability.
Fowler CD; Kenny PJ
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):533-44. PubMed ID: 24055497
[TBL] [Abstract][Full Text] [Related]
5. Chronic Nicotine Exposure Alters the Neurophysiology of Habenulo-Interpeduncular Circuitry.
Arvin MC; Jin XT; Yan Y; Wang Y; Ramsey MD; Kim VJ; Beckley NA; Henry BA; Drenan RM
J Neurosci; 2019 May; 39(22):4268-4281. PubMed ID: 30867261
[TBL] [Abstract][Full Text] [Related]
6. β4-Nicotinic Receptors Are Critically Involved in Reward-Related Behaviors and Self-Regulation of Nicotine Reinforcement.
Husson M; Harrington L; Tochon L; Cho Y; Ibañez-Tallon I; Maskos U; David V
J Neurosci; 2020 Apr; 40(17):3465-3477. PubMed ID: 32184221
[TBL] [Abstract][Full Text] [Related]
7. Why flavored vape products may be attractive: Green apple tobacco flavor elicits reward-related behavior, upregulates nAChRs on VTA dopamine neurons, and alters midbrain dopamine and GABA neuron function.
Avelar AJ; Akers AT; Baumgard ZJ; Cooper SY; Casinelli GP; Henderson BJ
Neuropharmacology; 2019 Nov; 158():107729. PubMed ID: 31369741
[TBL] [Abstract][Full Text] [Related]
8. Addiction-related neuroadaptations following chronic nicotine exposure.
Wills L; Kenny PJ
J Neurochem; 2021 Jun; 157(5):1652-1673. PubMed ID: 33742685
[TBL] [Abstract][Full Text] [Related]
9. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
Smith LC; George O
Neuropharmacology; 2020 Nov; 178():108225. PubMed ID: 32758566
[TBL] [Abstract][Full Text] [Related]
10. Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.
Dani JA; De Biasi M
Cold Spring Harb Perspect Med; 2013 Jun; 3(6):. PubMed ID: 23732854
[TBL] [Abstract][Full Text] [Related]
11. Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.
Besson M; David V; Baudonnat M; Cazala P; Guilloux JP; Reperant C; Cloez-Tayarani I; Changeux JP; Gardier AM; Granon S
Psychopharmacology (Berl); 2012 Mar; 220(1):1-14. PubMed ID: 21901321
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic receptor-based therapeutics and candidates for smoking cessation.
Dwoskin LP; Smith AM; Wooters TE; Zhang Z; Crooks PA; Bardo MT
Biochem Pharmacol; 2009 Oct; 78(7):732-43. PubMed ID: 19523455
[TBL] [Abstract][Full Text] [Related]
13. Neurobiological Mechanisms of Nicotine Reward and Aversion.
Wills L; Ables JL; Braunscheidel KM; Caligiuri SPB; Elayouby KS; Fillinger C; Ishikawa M; Moen JK; Kenny PJ
Pharmacol Rev; 2022 Jan; 74(1):271-310. PubMed ID: 35017179
[TBL] [Abstract][Full Text] [Related]
14. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
Bagdas D; Alkhlaif Y; Jackson A; Carroll FI; Ditre JW; Damaj MI
Neuropharmacology; 2018 Aug; 138():72-79. PubMed ID: 29860196
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Benowitz NL
Clin Pharmacol Ther; 2008 Apr; 83(4):531-41. PubMed ID: 18305452
[TBL] [Abstract][Full Text] [Related]
16. α3β4 nicotinic receptors in the medial habenula and substance P transmission in the interpeduncular nucleus modulate nicotine sensitization.
Eggan BL; McCallum SE
Behav Brain Res; 2017 Jan; 316():94-103. PubMed ID: 27531501
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
Balfour DJ; Fagerström KO
Pharmacol Ther; 1996; 72(1):51-81. PubMed ID: 8981571
[TBL] [Abstract][Full Text] [Related]
18. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.
D'Souza MS; Markou A
Addict Sci Clin Pract; 2011 Jul; 6(1):4-16. PubMed ID: 22003417
[TBL] [Abstract][Full Text] [Related]
19. Nicotine and behavioral sensitization.
Mao D; McGehee DS
J Mol Neurosci; 2010 Jan; 40(1-2):154-63. PubMed ID: 19669944
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.
Gotti C; Guiducci S; Tedesco V; Corbioli S; Zanetti L; Moretti M; Zanardi A; Rimondini R; Mugnaini M; Clementi F; Chiamulera C; Zoli M
J Neurosci; 2010 Apr; 30(15):5311-25. PubMed ID: 20392953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
